When to Recheck a Mildly Low GFR
If your GFR is mildly reduced (60–89 mL/min/1.73 m² or 45–59 mL/min/1.73 m²), you must first confirm chronicity by repeating the measurement within 2–4 weeks if no prior values exist, then establish a monitoring schedule based on the combination of your GFR category and degree of albuminuria.
Confirm Chronicity First
- Chronic kidney disease requires that reduced eGFR persist for ≥3 months; a single abnormal value may represent acute kidney injury rather than chronic disease 1.
- If you have no historical eGFR measurements within the past 3 months, repeat serum creatinine and eGFR within 2–4 weeks to distinguish CKD from reversible acute kidney injury 2.
- Always measure urinary albumin-to-creatinine ratio (UACR) on a random spot urine sample at the time of initial eGFR assessment, because albuminuria classification is essential for risk stratification and determines monitoring frequency 1, 2.
Risk-Stratified Monitoring Frequency
Once chronicity is confirmed (≥3 months of reduced eGFR or presence of kidney damage markers), your recheck interval depends on both your eGFR category and your UACR level:
For eGFR 45–59 mL/min/1.73 m² (CKD Stage 3a)
| UACR Level | Risk Category | Monitoring Frequency |
|---|---|---|
| < 30 mg/g | Low risk | Twice per year (every 6 months) [1] |
| 30–300 mg/g | Moderate-to-high risk | Three times per year (every 4 months) [1] |
| > 300 mg/g | Very high risk | Four times per year (every 3 months) + nephrology referral [1] |
For eGFR 30–44 mL/min/1.73 m² (CKD Stage 3b)
| UACR Level | Risk Category | Monitoring Frequency |
|---|---|---|
| < 30 mg/g | Moderate risk | Twice per year (every 6 months) [1] |
| 30–300 mg/g | High risk | Three times per year (every 4 months) [1] |
| > 300 mg/g | Very high risk | Four times per year (every 3 months) + nephrology referral [1] |
For eGFR 60–89 mL/min/1.73 m² (CKD Stage 2)
- This eGFR range is NOT considered CKD unless kidney damage is present (UACR ≥30 mg/g, hematuria, structural abnormalities, or biopsy-proven disease) 2.
- If UACR < 30 mg/g and no other kidney damage markers exist, this is normal kidney function and does not require CKD monitoring 2.
- If UACR ≥30 mg/g is confirmed, monitor eGFR and UACR annually for low risk (UACR 30–300 mg/g) or 2–3 times per year for high risk (UACR >300 mg/g) 2.
Additional Monitoring Considerations
- Electrolytes (sodium, potassium, chloride, bicarbonate) should be checked every 3–5 months in Stage 3b CKD to detect hyperkalemia and metabolic acidosis 1.
- Mineral-bone disorder screening (intact PTH, calcium, phosphate, 25-hydroxyvitamin D) is mandatory at least once when eGFR falls below 45 mL/min/1.73 m², because PTH begins to rise when eGFR drops below 60 mL/min/1.73 m² 1.
- Hemoglobin should be measured every 6 months in Stage 3b CKD to detect anemia, which becomes increasingly prevalent at this stage 1.
When to Recheck More Frequently
Immediate repeat testing (within 2–4 weeks) is warranted if:
- You are starting or adjusting medications that affect kidney function (ACE inhibitors, ARBs, diuretics, NSAIDs, metformin) 1.
- You experience acute illness, dehydration, or volume depletion 1.
- Your eGFR shows an unexplained decline of >5 mL/min/1.73 m² from baseline 1.
Nephrology Referral Triggers
Refer to nephrology immediately if any of the following occur:
- eGFR declines by >5 mL/min/1.73 m² per year (rapid progression) 1.
- eGFR approaches or falls below 30 mL/min/1.73 m² (transition to Stage 4 CKD) 1.
- UACR >300 mg/g with persistent increase despite optimal management 1.
- Resistant hypertension (blood pressure uncontrolled on ≥3 antihypertensive agents including a diuretic) 1.
Common Pitfalls to Avoid
- Do not rely on serum creatinine alone; always calculate eGFR using a validated equation (CKD-EPI 2021) 1.
- Do not omit albuminuria testing; eGFR and UACR provide independent prognostic information for cardiovascular events, CKD progression, and mortality 1.
- Do not assume a single abnormal eGFR represents chronic disease; confirm persistence over ≥3 months or review prior values 1.
- Do not delay nephrology referral when eGFR is declining rapidly or approaching 30 mL/min/1.73 m², as timely referral improves outcomes 1.